All News J. Molner

Equities

MOLNRIPO

EE3100109034

Delayed Nasdaq Tallinn Other stock markets 10:24:24 03/06/2024 BST			5-day change	1st Jan Change
13.1 ^EUR	-5.76%		-2.24%	-4.73%

04-30	J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	CI
03-04	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	04-30	CI
J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	03-04	CI
Certain Ordinary Shares of J. Molner AS are subject to a Lock-Up Agreement Ending on 7-NOV-2023.	11-06	CI
J. Molner AS Signs Licensing Agreement for Five Approved Drugs in the US	06/09/23	CI
J. Molner AS has completed an IPO in the amount of Ã‡1.199998 million.	07/11/22	CI
J. Molner AS has filed an IPO in the amount of Ã‡1.199998 million.	12/10/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW